药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Bevantolol
Pomalidomide
The serum concentration of Pomalidomide can be increased when it is combined with Enzalutamide.
Bevantolol
Dacomitinib
The serum concentration of Dacomitinib can be increased when it is combined with Enzalutamide.
Bevantolol
Ceritinib
The serum concentration of Ceritinib can be increased when it is combined with Enzalutamide.
Bevantolol
Talazoparib
The serum concentration of Talazoparib can be increased when it is combined with Enzalutamide.
Bevantolol
Potassium cation
Potassium cation may increase the excretion rate of Enzalutamide which could result in a lower serum level and potentially a reduction in efficacy.
Bevantolol
Efonidipine
Efonidipine may increase the excretion rate of Enzalutamide which could result in a lower serum level and potentially a reduction in efficacy.
Bevantolol
Potassium
Potassium may increase the excretion rate of Enzalutamide which could result in a lower serum level and potentially a reduction in efficacy.
Bevantolol
Bromotheophylline
Bromotheophylline may increase the excretion rate of Enzalutamide which could result in a lower serum level and potentially a reduction in efficacy.
Bevantolol
Epitizide
Epitizide may increase the excretion rate of Enzalutamide which could result in a lower serum level and potentially a reduction in efficacy.
Bevantolol
Xipamide
Xipamide may increase the excretion rate of Enzalutamide which could result in a lower serum level and potentially a reduction in efficacy.
Bevantolol
Muzolimine
Muzolimine may increase the excretion rate of Enzalutamide which could result in a lower serum level and potentially a reduction in efficacy.
Bevantolol
Clopamide
Clopamide may increase the excretion rate of Enzalutamide which could result in a lower serum level and potentially a reduction in efficacy.
Bevantolol
Fenquizone
Fenquizone may increase the excretion rate of Enzalutamide which could result in a lower serum level and potentially a reduction in efficacy.
Bevantolol
Clofenamide
Clofenamide may increase the excretion rate of Enzalutamide which could result in a lower serum level and potentially a reduction in efficacy.
Bevantolol
Clorexolone
Clorexolone may increase the excretion rate of Enzalutamide which could result in a lower serum level and potentially a reduction in efficacy.
Bevantolol
Cyclopenthiazide
Cyclopenthiazide may increase the excretion rate of Enzalutamide which could result in a lower serum level and potentially a reduction in efficacy.
Bevantolol
Mebutizide
Mebutizide may increase the excretion rate of Enzalutamide which could result in a lower serum level and potentially a reduction in efficacy.
Bevantolol
Mefruside
Mefruside may increase the excretion rate of Enzalutamide which could result in a lower serum level and potentially a reduction in efficacy.
Bevantolol
Meticrane
Meticrane may increase the excretion rate of Enzalutamide which could result in a lower serum level and potentially a reduction in efficacy.
Bevantolol
Cicletanine
Cicletanine may increase the excretion rate of Enzalutamide which could result in a lower serum level and potentially a reduction in efficacy.